tiprankstipranks
Tourmaline Bio (TRML)
NASDAQ:TRML
US Market

Tourmaline Bio (TRML) Income Statement

Compare
505 Followers

Tourmaline Bio Income Statement

Last quarter (Q3 2024), Tourmaline Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tourmaline Bio's net income was $-20.18M. See Tourmaline Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -33.00K$ -6.00K$ -623.00K$ -447.00K$ -379.00K
Operating Expenses
$ 45.41M$ 19.70M$ 904.00$ 22.24M$ 18.00M
Depreciation and Amortization
$ 33.00K$ 6.00K$ 904.00$ 447.00K$ 379.00K
EBITDA
$ -45.38M$ -19.70M$ -46.88M$ -22.24M$ -17.78M
Operating Income
$ -45.41M$ -19.70M$ -904.00$ -22.68M$ -18.38M
Other Income/Expenses
$ 3.29M$ 0.00$ -47.83M$ -23.00K$ 223.00K
Pretax Income
$ -42.12M$ -19.70M$ -904.00$ -22.71M$ -18.16M
Net Income
$ -42.12M$ -19.70M$ -904.00$ -22.71M$ -18.16M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -8.87$ -0.97$ 0.00$ -33.97$ -4.39
Diluted EPS
$ -8.87$ -0.97$ 0.00$ -33.97$ -4.39
Weighted Average Shares Outstanding
4.75M 20.34M 10.88M 668.51K 4.13M
Weighted Average Shares Outstanding (Diluted)
4.75M 20.34M 10.88M 668.51K 4.13M
Currency in USD

Tourmaline Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis